Drug Discovery · Cambridge, MA · Founded 2022 · Privately Held (backing)
Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome. Stylus Medicine is based in Cambridge, MA and was founded in 2022. It was valued at $114 million at its early-stage round in May 2025, the last priced event on record. It has raised $93 million across 1 recorded round; the latest was an $85 million Series A in May 2025.
PMV mark · valuation
$114.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$93.0M
Last round
Early Stage VC (Series A)
May 2025
Team — not yet on record
No current team members for Stylus Medicine are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stylus Medicine with a free account
·The complete investor list: 12 names
·Watch Stylus Medicine: the Monday email on marks, rounds and moves
